Antapodia Therapeutics is a science-driven and developmental-stage biopharmaceutical company providing breakthrough solutions for treating aggressive human cancers. The company leverages next-generation nanocarrier and gene-therapy technologies to develops first-in-class invadopodia-targeted siRNA and antibody therapies. These novel therapeutics have shown dramatic therapeutic efficacy in different types of cancers and are expected to have a high opportunity of clinical success.